Precision BioSciences, Inc.
DTIL
$4.62
-$0.13-2.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 51.14M | 68.70M | 75.10M | 87.64M | 57.53M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 51.14M | 68.70M | 75.10M | 87.64M | 57.53M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 51.14M | 68.70M | 75.10M | 87.64M | 57.53M |
| SG&A Expenses | 35.66M | 35.42M | 34.31M | 35.17M | 36.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 95.23M | 94.86M | 91.30M | 94.93M | 92.10M |
| Operating Income | -44.09M | -26.16M | -16.21M | -7.29M | -34.57M |
| Income Before Tax | -21.99M | 7.17M | 11.48M | 15.79M | -19.99M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.99 | 7.17 | 11.48 | 15.79 | -19.99 |
| Earnings from Discontinued Operations | -- | -- | -2.86M | 1.18M | -7.68M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.99M | 7.17M | 8.62M | 16.97M | -27.67M |
| EBIT | -44.09M | -26.16M | -16.21M | -7.29M | -34.57M |
| EBITDA | -41.43M | -22.76M | -11.98M | -2.16M | -28.56M |
| EPS Basic | -1.98 | 1.93 | 0.08 | 0.23 | -7.60 |
| Normalized Basic EPS | -1.21 | 1.29 | 0.32 | -0.25 | -3.71 |
| EPS Diluted | -2.02 | 1.89 | 0.05 | 0.20 | -7.60 |
| Normalized Diluted EPS | -1.23 | 1.27 | 0.30 | -0.27 | -3.71 |
| Average Basic Shares Outstanding | 31.55M | 27.31M | 23.16M | 19.71M | 16.54M |
| Average Diluted Shares Outstanding | 31.59M | 27.36M | 23.20M | 19.76M | 16.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |